- About Us
- Nano-Social Network
- Nano Consulting
- My Account
September 28th, 2007
There is some good news for insulin-dependent diabetic patients. Soon, they may not have to undergo painful jabs of insulin injection to keep their sugar levels under control. They may just have to pop in a tablet or gulp down a spoon of the medicine.
Thiruvananthapuram-based Sree Chitra Tirunal Institute of Medical Sciences and Technology has successfully demonstrated the possibility of developing an oral insulin preparation in experiments on mice and is now getting ready to conduct clinical trials with human subjects to establish its efficacy and viability.
Disclosing this, Director of the Institute K.Mohandas said the technology was based on the cutting edge science of nanotechnology. The technology, which recently cleared the proof of concept stage in experiments with mice, has been transferred to US Vitamin, a Mumbai-based company for further development. "We are now getting ready to conduct clinical trials in association with US Vitamin. We will decide whether it should be a tablet or in a liquid form later."
|Related News Press|
ATTOPSEMI Technology Joins FDXcelerator Program to Deliver Advanced Non-Volatile Memory IP to GLOBALFOUNDRIES 22 FDX® Technology Platform: Leading-edge I-fuse™ brings higher reliability, smaller cell size and ease of programmability for consumer, automotive, and IoT applications March 27th, 2017
Leti and HORIBA Scientific to Host Webinar on Ultrafast Characterization Tool: Plasma Profiling Time-of-Flight Mass Spectrometer Tool Cuts Optimization Time In Layer Deposition and Fabrication of Wide Range of Applications March 27th, 2017
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016